Oncolytics Biotech (ONCY) Shares Outstanding (2009 - 2025)

Oncolytics Biotech (ONCY) has 11 years of Shares Outstanding (Entity) data on file, last reported at $438.1 million in Q1 2023.

• On a quarterly basis, Shares Outstanding (Entity) rose 3.25% year-over-year to $438.1 million in Q1 2023; TTM through Mar 2023 was $438.1 million, a 3.25% increase from a year earlier, with the FY2022 full-year figure at $424.0 million, up 4.53% from the prior year.
• Shares Outstanding (Entity) for Q1 2023 stood at $438.1 million, up from $406.1 million in the prior quarter.
• Over the last five years, Shares Outstanding (Entity) for ONCY reached as high as $438.1 million in Q1 2023 and fell as low as $159.3 million in Q4 2019.
• Historically, Shares Outstanding (Entity) has averaged $328.9 million across 5 years, with a median of $372.8 million in 2021.
• Across the five-year window, Shares Outstanding (Entity) jumped 84.51% in 2020 and increased 0.7% in 2022, its largest moves.
• Year by year, Shares Outstanding (Entity) stood at $159.3 million in 2019, then soared by 84.51% to $294.0 million in 2020, then jumped by 37.2% to $403.3 million in 2021, then advanced by 0.7% to $406.1 million in 2022, then climbed by 7.87% to $438.1 million in 2023.
• Per Business Quant data, the three most recent Shares Outstanding (Entity) figures were $438.1 million in Q1 2023, $406.1 million in Q4 2022, and $424.9 million in Q3 2022.